How many insider declarations has Bazemore Robert B filed?

Bazemore Robert B has filed 3 public insider declarations with SEC (Form 4).

What is Bazemore Robert B's role?

Bazemore Robert B's reported role is not specified by the regulator across the filings.

Which companies does Bazemore Robert B report trades for?

Bazemore Robert B reports trades for 2 companies, including Akari Therapeutics Plc.

← Executives ★ Sign in to follow

BR

Bazemore Robert B

OFFICER

·SEC (Form 4)

Akari Therapeutics Plc Ardelyx, INC.

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the full record of transactions filed by Bazemore Robert B. Director active across 2 companies, notably Akari Therapeutics Plc. Cumulatively, 3 disclosures have been logged. Activity tracked since 6 March 2025. The latest transaction was filed on 18 June 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.

Companies and markets linked to Bazemore Robert B

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Akari Therapeutics Plc (US)Ardelyx, INC. (US)

申报3 总计

◆

Bazemore Robert B

Director高管2026年6月16日Ardelyx, INC.

0SEC ↗

26,455 股Common StockSEC:0001620152-26-000005:0

◆

Bazemore Robert B

Director高管2025年6月18日Ardelyx, INC.

0SEC ↗

41,551 股0Common StockSEC:0001628280-25-032730:0

◆

Bazemore Robert B

Director高管2025年3月6日Akari Therapeutics Plc

US$49,99919SEC ↗

44,642 股@ US$1.12100.0% 占其流量American Depositary Shares representing Ordinary SharesSEC:0000950170-25-036482:0

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

BR

Bazemore Robert B

OFFICER

·SEC (Form 4)

Akari Therapeutics Plc Ardelyx, INC.

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the full record of transactions filed by Bazemore Robert B. Director active across 2 companies, notably Akari Therapeutics Plc. Cumulatively, 3 disclosures have been logged. Activity tracked since 6 March 2025. The latest transaction was filed on 18 June 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.